Studies in MEMO use highly confidential, although anonymised, medical data.
CONFIDENTIALITY AND ETHICS IN
MEMO
Studies
in MEMO use highly confidential, although anonymised, medical data. MEMO has an
agreement with the Local Medical Committee of the British Medical Association
never to divulge person-specific or GP-specific data, unless it is to a doctor
requesting information on one of his or her own patients. All staff in MEMO
sign confidentiality agreements and all databases are registered for research
purposes with the Data Protection Officer. All studies in MEMO use
de-identified data. The anonymisation process uses a randomly selected number
mapped to the CHI number. The random number then becomes the link between
databases. The Data Protection Officer is the only person that holds the
mapping key. Ethics committees and Caldicott Guardians must approve study
protocols before each study begins. Approved studies are logged in MEMO and may
be audited by Caldicott Guardians at anytime. Any changes to a study protocol
require resubmission to the ethics and Caldicott Guardians for approval of the
change. As data protection and ethical issues continue to evolve, MEMO will
ensure that it meets the standards in both these areas (Data Protection Act,
1998).
Related Topics
TH 2019 - 2025 pharmacy180.com; Developed by Therithal info.